SOPHiA GENETICS S.A. (SOPH): Price to Earnings Adjusted for Growth Rate
SOPHiA GENETICS SA (SOPH) provides cloud services for genome analysis across hundreds of global laboratories. The PEG ratio confirms the market valuation, where 0.00 determines this specific parameter level. High physician confidence in AI-driven cancer diagnostics strengthens the company's status, while software code optimization minimizes the load on data center servers.
Analytical breakdowns for SOPHiA GENETICS SA (SOPH)
- price and consensus price forecast:
- stock exchange capitalization data:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient SOPHiA GENETICS SA|SOPH - Long-Term Debt to Capital|Short-Term Debt to Capital sophiagenetics.com|SOPH - Company Total Debt|Debt to Net Assets Ratio SOPHiA GENETICS S.A.|SOPH - Company Long-Term Debts|Short-Term Indebtedness SOPHiA GENETICS SA|Immediate Liquidity sophiagenetics.com
- earnings and valuation multiples indicators:
SOPH - Company Net Income|Net Profit Forecast SOPHiA GENETICS SA|SOPH - P/E Multiple|Projected Price to Earnings Ratio sophiagenetics.com|SOPH - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio SOPHiA GENETICS S.A.|SOPH - Operating profit EBITDA|Net earnings per share for the last four quarters SOPHiA GENETICS SA|SOPH - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months sophiagenetics.com|SOPH - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year SOPHiA GENETICS SA
Summary company analytics:Sophia Genetics, SOPH
For fundamental asset screening, it is critical to correlate a company's market value with its earnings dynamics. By analyzing the PEG ratio, an investor determines the degree of a security's undervaluation: a value below one signals an attractive price relative to the expansion rates of the SOPHiA GENETICS SA (SOPH) AI platform within the bioinformatics and precision medicine sector.
Competing companies
Growth-Adjusted Market Cap to Net Income Veeva Systems|Price/Earnings to Growth Ratio Doximity Corp DOCS|HealthEquity Building (HQY) - Price to Earnings Adjusted for Growth Rate|WAY - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio CRVL|PRVA: PEG Multiple|Huron Consulting Group Inc. - Growth-Adjusted Payback Ratio|CERT (Certara Corp) - PEG Multiple|Omnicell Health (OMCL) - Growth-Adjusted Market Cap to Net Income|PEG Multiple GDRX|PEG Multiple schrodinger.com (SDGR)|Phreesia - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio OMDA|Evolent - PEG Multiple|Price to Net Income Growth Ratio HealthStream Learning (HSTM)|DH: PEG Multiple|Price to Earnings Adjusted for Growth Rate consensus.com (CCSI)|Price/Earnings to Growth Ratio agilon health|Growth-Adjusted P/E Ratio ABSI (Absci Corp)|PEG Multiple SY|NRC - Price to Earnings Adjusted for Growth Rate|Spok Holdings, Inc. - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio OPRX (optimizerx.com)|TruBridge - PEG Multiple|Growth-Adjusted Market Cap to Net Income Simulations Plus Inc SLP|HCAT: PEG Multiple|Price/Earnings to Growth Multiple CareCloud|Price/Earnings to Growth Ratio Research Solutions|DLH Holdings Corp (DLHC) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple ONMD (OneMedNet Corporation)|SCNX (Scienture Holdings) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Healthcare Triangle Corp HCTI|Growth-Adjusted Market Cap to Net Income iSpecimen Inc (ISPC)|Bullfrog AI Holdings Inc - PEG Multiple|WORX - PEG Multiple|MSP Recovery (MSPR) - Price/Earnings to Growth Ratio|ICCT - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio TRxADE|Price to Earnings Adjusted for Growth Rate Orgenesis Corporation ORGS|Price/Earnings to Growth Ratio R1 RCM Inc. (RCM)|SHCR: Market Cap to Earnings and Growth Ratio|PEG Multiple STRM (Streamline Health)|Growth-Adjusted Payback Ratio SYRA|ApolloMed - PEG Multiple|Growth-Adjusted Market Cap to Net Income Model N Corporation MODN|NXGN (NextGen Healthcare) - Price/Earnings to Growth Multiple
